North American venture capital funding surged to a record high in the first half of 2026, driven by an unprecedented boom in mega-rounds for leading artificial intelligence (AI) companies—while IPO and M&A activity simultaneously hit historic peaks. The scale of capital moving into a small number of perceived category winners is reshaping both private and public market expectations across the tech landscape.
Data compiled by Crunchbase as of July 2 shows startups in the U.S. and Canada raised a combined $392 billion in the first six months of 2026. Second-quarter funding totaled $137.2 billion—down from the first quarter, but still the second-largest quarterly tally on record. The standout feature of the rally was concentration: the jump in dollars was fueled less by a broad rise in deal count than by a handful of outsized financings.
Late-stage capital clusters around AI leaders
Late-stage and technology growth funding reached roughly $101 billion in Q2, ranking among the highest levels ever recorded for the segment. Much of that total was attributable to a small set of mega-deals, led by Anthropic’s $65 billion raise, which implied a post-money valuation of $965 billion. The round included major participation from Altimeter Capital, Dragoneer, Greenoaks, and Sequoia Capital, alongside strategic investments reportedly totaling $5 billion from Amazon and $10 billion from Google. Anthropic later filed confidentially for an IPO in June, signaling that private-market price discovery is increasingly converging with public-market ambitions.
Defense technology unicorn Anduril Industries also secured a $5 billion Series H round led by Thrive Capital and Andreessen Horowitz, reinforcing the market’s tilt toward large, late-stage bets on a narrow set of leaders rather than a broad-based expansion in venture activity.
Early-stage dollars rise, but deals fall
Early-stage funding remained robust despite fewer transactions. Crunchbase data shows Q2 early-stage investment in North America came in slightly above $31 billion—nearly double year-over-year and up about 15% from Q1. However, the number of deals fell to the lowest level in five quarters, underscoring how capital is being deployed into fewer companies at higher check sizes.
AI again dominated early-stage allocation. Physical-AI startup Prometheus raised $12 billion—accounting for more than 40% of total early-stage funding in the quarter—and counts Jeff Bezos as a co-founder. Other notable raises included $700 million for Hark, $500 million for Flourish, and $400 million for Generalist AI, reflecting a market increasingly willing to price early traction at late-stage-like levels when the narrative aligns with 'AI platform' potential.
Seed slows, even as “super-sized” seed rounds persist
Seed and angel activity cooled. Seed funding dropped to $4.9 billion in Q2, down 15% quarter-over-quarter and 27% year-over-year, with deal volumes also declining. Crunchbase noted that seed data is often backfilled over subsequent weeks or months, meaning totals may revise upward. Still, the downshift suggests the broader base of new-company formation is not keeping pace with the surge at the top end of the market.
Even so, unusually large seed rounds continued in AI. Research-driven foundational AI startup Mirendil raised $200 million, and at least five companies secured seed or angel rounds surpassing $100 million during the quarter. The pattern points to an 'early land-grab' dynamic in AI, where investors are paying premiums to secure exposure before competitive moats fully form.
AI captures roughly 80% of Q2 venture dollars
AI was the defining theme of the quarter. Crunchbase estimates that close to 80% of total Q2 venture investment across stages flowed into AI-related startups, with aggregate AI funding nearly tripling from a year earlier. While the headline figure trailed Q1—largely because the first quarter included OpenAI’s massive $122 billion financing—the underlying trend remained clear: the market is increasingly underwriting the assumption that the AI era will produce a small number of 'mega-winners' worth concentrating capital behind.
Anthropic, Prometheus, and Anduril collectively accounted for the bulk of Q2’s AI total, reinforcing a winner-takes-most dynamic in which investors prioritize scale, distribution, and perceived defensibility over diversified exposure across the ecosystem.
Exit markets ignite, led by SpaceX in IPOs and M&A
Venture 'liquidity' also accelerated sharply. The quarter’s marquee event was SpaceX’s IPO in June, which reportedly raised $75 billion—setting a record for the largest corporate public offering. SpaceX’s market capitalization has since been estimated around $2.1 trillion, placing it among the most valuable publicly traded companies in the U.S.
Other notable public debuts included AI infrastructure and chip design firm Cerebras Systems, which raised $5.6 billion in a May IPO, along with quantum computing company Quantinuum, which listed on Nasdaq in June. Small modular reactor developer X-energy also moved into the public markets, broadening the exit window beyond consumer and software into frontier technology categories.
In M&A, SpaceX again took center stage, agreeing to acquire AI coding tool Cursor and its parent company Anysphere for $60 billion—described as a record startup acquisition. The deal followed the announcement of a purchase option in April and was finalized after the IPO. Elsewhere, Eli Lilly ($LLY) agreed to buy gene-therapy developer Kelonia Therapeutics in a cash deal valued at up to $7 billion, while Qualcomm ($QCOM) acquired AI chip startup Modular for $4 billion. Salesforce ($CRM) also announced an acquisition of AI-driven customer experience tools provider Finn.
A market in uncharted territory
Market observers describe the first half of 2026 as entering a zone that is difficult to compare with prior venture cycles: record fundraising totals, near-trillion-dollar private valuations, and simultaneous all-time highs in both IPO proceeds and startup M&A. Whether this pace can persist remains uncertain, but the direction of travel is increasingly defined by the same premise—AI will mint a small set of dominant platforms, and capital markets are racing to identify them early.
With both Anthropic and OpenAI signaling IPO intentions around, or potentially above, the $1 trillion valuation level, and billion-dollar-plus rounds becoming less exceptional, the central question for the second half of the year is no longer whether the AI boom will attract money—but which companies will ultimately justify the market’s concentrated bets.
🔎 Market Interpretation
- Record-setting H1 2026 venture funding: North American startups raised $392B in H1 2026, with Q2 at $137.2B (second-highest quarter on record), indicating a historically loose funding environment.
- Extreme capital concentration: Funding growth is driven more by mega-rounds than by broader deal volume—suggesting a “barbell” market where a few perceived winners absorb most capital.
- AI dominates allocation: Roughly ~80% of Q2 venture dollars flowed to AI-related startups; even when Q2 trailed Q1 (which included OpenAI’s $122B round), the underlying trend remains acceleration toward AI.
- Late-stage froth + public-market convergence: Anthropic’s $65B round at a $965B post-money valuation, followed by a confidential IPO filing, highlights private valuations approaching public-market scale and expectations.
- Exits re-open at full throttle: The same quarter saw historic highs in IPOs and M&A, led by SpaceX’s blockbuster IPO and record acquisition activity—improving liquidity narratives that can further fuel late-stage pricing.
- Signal to the broader ecosystem: Early-stage dollars rose but deals fell; seed cooled—implying that while capital is abundant, it is being deployed selectively, not broadly supporting new company formation.
💡 Strategic Points
- “Winner-takes-most” playbook is back: Investors are prioritizing scale, distribution, and defensibility over diversification—raising the bar for non-leader startups to secure funding without a clear wedge or moat.
- Prepare for fewer, larger rounds: With deal counts down but dollars up (especially early-stage), founders should expect higher conviction thresholds, more diligence, and greater emphasis on narrative + traction.
- IPO readiness is becoming a competitive advantage: Anthropic’s IPO steps and SpaceX’s listing imply that late-stage companies may benefit from earlier investments in governance, reporting, and predictable unit economics (or a credible path to them).
- Early-stage “mega-seed” is redefining entry pricing: Oversized seed rounds (e.g., Mirendil’s $200M; multiple $100M+ seeds) can accelerate land-grabs but also introduce expectation risk (growth demands, compressed error tolerance).
- Strategics are shaping outcomes: Reported strategic participation (e.g., Amazon/Google in Anthropic) suggests platform incumbents are using capital to secure supply, influence, and ecosystem positioning.
- M&A exit paths are widening beyond software: IPOs and listings across AI chips/infra, quantum, and energy (SMRs) suggest a broader exit window for “frontier tech,” potentially improving long-horizon venture underwriting.
- Key risk to monitor: If public multiples or growth expectations reset, highly concentrated portfolios and near-trillion private marks could face sharper repricing than diversified venture eras.
📘 Glossary
- Mega-round: An unusually large private funding round (often billions of dollars) that can materially impact quarterly funding totals and valuations.
- Late-stage / Growth funding: Capital raised by more mature startups (often pre-IPO) to scale aggressively, expand markets, or solidify dominance.
- Early-stage funding: Typically Series A/B capital used to prove product-market fit, scale go-to-market, and build repeatable growth.
- Seed / Angel: The earliest funding used to validate a concept, build an initial product, and assemble a founding team; often most sensitive to macro risk.
- Post-money valuation: The company’s valuation after new capital is added (pre-money valuation + new investment).
- Confidential IPO filing: A process allowing companies to submit IPO paperwork privately before making it public, often used to manage timing and market risk.
- IPO (Initial Public Offering): When a company first sells shares to the public on a stock exchange, providing liquidity and public price discovery.
- M&A (Mergers & Acquisitions): Corporate transactions where companies buy, merge with, or absorb others—often a major liquidity path for startups.
- Deal count: The number of funding transactions; when down while dollars are up, it signals capital concentration into fewer companies.
- Winner-takes-most dynamic: Market structure where a small number of leaders capture disproportionate value due to scale advantages, network effects, or platform control.
- Strategic investment: Funding by a corporate incumbent (not just a financial VC) to gain ecosystem leverage, supply access, or product integration benefits.
Comment 0